How is sensitive data protected?

All documents are encrypted with AES-256-GCM at rest and TLS 1.2+ in transit. A GDPR anonymization layer removes PII before any AI processing. Hosted on Vercel + Supabase (both SOC 2 Type II); Decision Intel’s own product-level audit is targeted for Q4 2026.

How long does integration take?

Less than 30 minutes. Upload documents directly, connect via OAuth for Slack, or use our REST API for bulk processing.

How does outcome tracking work?

Outcomes are detected automatically from follow-up documents, Slack messages, and web intelligence. You confirm with one click. Each reported outcome makes your future analyses more accurate.

How is Decision Intel different from ChatGPT or a general AI assistant?

ChatGPT gives one opinion from one model: ungoverned, untraceable, unaudited. Decision Intel is the reasoning audit platform. Most tools audit your data; we audit your reasoning — and catch the fatal blind spots in strategic memos before the committee does. It measures the noise in your reasoning the same way Kahneman did in the insurance underwriter study, simulates an AI boardroom of CEO, CFO, and board personas, runs what-if interventions against a 143-case public reference library, and compounds every confirmed outcome back into a calibrated Decision Quality Index your audit committee can defend. Not a chatbot; a reasoning audit, checkable from memo to outcome.

Which cognitive biases caused Pfizer's collapse?

5 bias patterns are documented in this case, led by Optimism Bias. The full set: Planning Fallacy, Optimism Bias, Sunk Cost Fallacy, Overconfidence Bias, Anchoring Bias. Each is mapped to Decision Intel's 22-bias R²F taxonomy with stable IDs and academic citations.

What is Decision Intel's reasoning audit?

Decision Intel runs a 12-node Recognition-Rigor Framework (R²F) pipeline on strategic memos, detecting cognitive biases from a 22-bias canonical taxonomy and producing a Decision Quality Index (DQI) score. The audit produces a hashed, tamper-evident Decision Provenance Record (DPR) suitable for audit-committee review.

All case studies

Catastrophic failureHealthcare2006

Pfizer

Pfizer Torcetrapib Clinical Trial Failure

Estimated impact: $800M+ direct investment; $21B market cap loss

F14

Decision Quality Index (simulated)

Critical · 5 biases detected, 2 toxic combinations

Pfizer invested $800M in torcetrapib, a cholesterol drug designed to raise HDL ("good cholesterol"). The Phase III trial was terminated early when it increased death rates by 60%. Pfizer had built an entire manufacturing facility before the trial completed, committing to production before efficacy was proven.

Decision context

Whether to invest in manufacturing capacity and commercial launch preparations before Phase III clinical trial results confirmed safety and efficacy.

Decision anatomy

Monetary stakes

Very high

Dissent suppressed

Time pressure

Present

Unanimous consensus

Decision participants

Dissent encouraged

External advisors

Iterative process

Red = risk factor present · Green = protective factor present

Deep hindsight-stripped analysis coming soon. This case is part of our ongoing backfill to reconstruct what the platform would have flagged at decision time. The summary and bias profile below are drawn from primary sources.

Biases present in the decision

Planning Fallacy

medium

★Optimism Bias

critical

Sunk Cost Fallacy

high

Overconfidence Bias

high

Anchoring Bias

high

★ Primary driver · Severity estimated from bias type and decision outcome

3D Decision Knowledge Graph

Pfizer · 5 biases, 2 toxic combinations

Drag to rotate · Scroll to zoom · Click to explore

Decision

Critical

High

Medium

Toxic

Bias Intensity Profile

Severity × confidence across 5 detected biases

Toxic combinations

!Optimism Trap

Overconfidence and availability bias create a systematically positive outlook that ignores base rates.

!Blind Sprint

Overconfidence combined with planning fallacy creates unstoppable momentum toward failure.

Reference class base rates

Across all 143 curated case studies in our library:

89%

base failure rate

-0%

partial / mixed

11%

base success rate

■ Failure■ Partial■ Success

Lessons learned

Optimism bias in drug development led Pfizer to build manufacturing before pivotal trial results — a classic premature commitment
The HDL hypothesis (raising HDL is always beneficial) was never rigorously validated, yet became consensus through anchoring to epidemiological correlations
Sunk cost in R&D made it harder to interpret ambiguous interim data objectively

Source: Barter et al., "Effects of Torcetrapib in Patients at High Risk for Coronary Events," NEJM (2007) (Academic Paper)

Pilot slots available

We caught these patterns in Pfizer's own record — before the outcome.

See the full bias auditwe ran — no login, no card. Then run the same 60-second audit on your own next memo.

See a live audit · no login Audit your own memo

Or leave your email, we'll run a strategic memo of your choosing and send the readout within a business day.

Audit your own decision

Workflows that fire on decisions like Pfizer’s

The same Recognition-Rigor Framework that documents this case audits memos in the same shape — before the outcome forces the lesson.

For CSOs and Heads of Strategic Planning

Strategic memo audit

Audit a strategic memo for cognitive bias and forecast errors in 60 seconds — before the board sees it.

Audit a strategic memo

For any high-stakes decision, before commitment

Decision pre-mortem

Run a structured pre-mortem before the decision is final — surface failure modes the room cannot see from the inside.

Run a pre-mortem

For CSOs and CEOs presenting to a board

Board deck pre-presentation audit

Audit a board deck before the presentation — predict the toughest questions the room will ask.

Audit your board deck

See all 6 workflows for the full audit-tool surface.

Related cases in Healthcare

Catastrophic failure2013

Yahoo

Yahoo-Tumblr Acquisition Write-Down

Failure2021

Biogen

Biogen Aduhelm Approval Controversy

Catastrophic failure2018

Carillion plc

Carillion Collapse

Catastrophic failure2005

Federal Bureau of Investigation

FBI Virtual Case File Project Failure

Lessons learned

Optimism bias in drug development led Pfizer to build manufacturing before pivotal trial results — a classic premature commitment

The HDL hypothesis (raising HDL is always beneficial) was never rigorously validated, yet became consensus through anchoring to epidemiological correlations

Sunk cost in R&D made it harder to interpret ambiguous interim data objectively